GLANDBSEGLAND PHARMA LIMITEDHighNegative
Announced Thu, 1 Oct, 2026 · 08:56 IST

Promoter Fosun Pharma sells 6% stake in Gland Pharma via open market

Promoter Stake Sell 1pctPromoter Below 50pctOwnership Changes View source PDFExplain this filing

GLAND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.2%1-day move
₹2905.00
prior close
₹2876.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2+0.0+0.4+0.4-0.2+3.5+8.6+5.4——————
Up moveDown movePending
AI summary

Fosun Pharma Industrial Pte Ltd, part of the promoter group, sold 98,97,000 equity shares (6% of total capital, 5.95% diluted) of Gland Pharma through open market on September 4, 2026. Post-sale promoter holding dropped from 51.76% to 45.76%, falling below the 50% mark. Sale value not disclosed in the filing.

Likely market impact

Promoter group now holds below 50%, raising potential corporate governance and control concerns for retail shareholders.